Skip to content
Banking, Finance Investment

Monash expert: RBA rates hold in anticipation of ‘Liberation Day’

Monash University < 1 min read

A Monash University expert is available to comment on the Reserve Bank of Australia’s decision today to hold interest rates. 

 

Dr Isaac Gross, Department of Economics, Monash Business School

Contact: + 61 490 819 643 or [email protected]

Read more of Dr Gross’ commentary here: Monash Lens  

The following can be attributed to Dr Gross: 

“The RBA held interest rates steady today as they await for the next set of quarterly inflation figures to see where the Australian economy is heading. January's inflation numbers were very low, and if that were to be repeated in April's numbers interest rate cuts would follow quickly. However the RBA is still concerned that they might have been a one off result and so will wait until their next meeting in May before committing to another cut.

 

“The big elephant in the room is Trump's tariffs due to be announced this week. Nobody knows how big they will be, who they will target and if other countries will retaliate. But the RBA will be watching carefully to see if this tariff tiff poses a substantial risk to the Australian economy.”

For any other topics on which you may be seeking expert comment, contact the Monash University Media Unit on +61 3 9903 4840 or [email protected] 

More from this category

  • Finance Investment, Medical Health Aged Care
  • 17/03/2026
  • 10:25
Jane Morgan Management

NeuroScientific Biopharmaceuticals (ASX:NSB) Advances StemSmart(TM) Manufacturing Scale-Up as Phase 2 Crohn’s Disease Trial Preparations Progress

Perth, Australia – 17 March 2026 | NeuroScientific Biopharmaceuticals Limited (ASX:NSB) has reached an important development milestone with the commencement of the first technology transfer manufacturing run of its patented StemSmart™ mesenchymal stem cell (MSC) process at leading Australian cell therapy manufacturer Q-Gen Cell Therapeutics. The initiation of the manufacturing run represents a key step in the transfer of the StemSmart™ manufacturing process to a large-scale clinical contract manufacturer that is then capable of providing adequate supply for Phase 2 clinical trials and future commercialisation. Q-Gen Cell Therapeutics, located within the QIMR Berghofer Medical Research Institute in Brisbane, is one…

  • Contains:
  • Environment, Finance Investment
  • 17/03/2026
  • 10:21
HESTA

HESTA launches search for Australia’s early childhood education champions

17 March 2026 The search for Australia’s most outstanding early childhood educators is underway with nominations opening today for the 2026 HESTA Early Childhood…

  • Contains:
  • Finance Investment, Oil Mining Resources
  • 17/03/2026
  • 09:57
Jane Morgan Management

Moab to acquire additional uranium tenements at Manyoni Project in Tanzania

Perth, Australia – 17 March 2026 Moab Minerals Limited (ASX: MOM) has strengthened its position at the Manyoni Uranium Project in Tanzania after securing the transfer of four uranium tenements adjacent to the project area from AuKing Limited (ASX: AKN). The tenements have been transferred to Moab’s Tanzanian subsidiary, Katika Resources Limited, and expand the Company’s exploration footprint across a prospective palaeochannel uranium system already mineralised at Manyoni. The acquisition forms part of Moab’s strategy to consolidate a strategic uranium landholding in central Tanzania and advance exploration across multiple targets associated with the broader palaeo-drainage system. Historical drilling across the…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.